Increased myocardial expression of Toll-like receptors 2 and 9 as a marker of active myocarditis and a possible predictor of therapeutic effectiveness

Close metadata

Objective: to investigate the myocardial expression of some structural proteins and markers of cellular proliferation and innate immunity for assessing their possible diagnostic and prognostic role in patients with chronic myocarditis. Subjects and methods. The investigation enrolled 23 patients (16 men; mean age, 52.0±12.4 years (range, 27 to 73) with various forms of noncoronarogenic myocardial injury who underwent right ventricular endomyocardial biopsy (n=4), intraoperative left ventricular biopsy (n=17) or autopsy (n=2). Prior to their morphological examination, the patients were divided into two groups: 1) 10 patients with dilated cardiomyopathy and presumptive myocarditis; 2) 13 patients with valvular heart disease, hypertrophic cardiomyopathy, myxoma, and chronic pulmonary thromboembolism, presumptively without myocarditis. Along with myocardial histological and immunohistochemical (IHC) examinations, the expression of vimentin, desmin, c-kit, Ki-67, and Toll-like receptors (TLR) 2 and 9 was determined. Polymerase chain reaction was used to identify whether herpes viruses of and parvovirus B19 genomes were present in the blood and myocardial samples; indirect ELISA was applied to estimate the blood level of antibodies against various cardiac antigens. Results. According to the histological findings, active/borderline lymphocytic myocarditis was diagnosed in all the patients (Group 1) and in 6 patients (Group 2) in conjunction with the underlying disease (only in 9 and 7 patients, respectively), viral genome was detected in the myocardium of 15 patients, including in 5 without morphological signs of myocarditis (parvovirus B19 (n=11), herpesvirus 6 (n=4), herpes simplex virus types 1 and 2 (n=1), Epstein-Barr virus (n=2), and cytomegalovirus (n=1)), and in the blood (n=4). A marked correlation was found between TLR2 and TLR9 expressions and the morphological pattern of active myocarditis in the absence of this correlation with the expression level of other studied markers. The expression level of TLR2 in patients with and without borderline myocarditis was 0 [0; 0,75] and in those with active myocarditis was 1.5 [1; 1,5] points; that of TLR9 was 2 [2; 2] and 4 [3; 4] points, respectively (p<0.001). The expression of TLR2 and TLR9 in patients with borderline myocarditis was lower than in those without myocarditis (0 [0; 0] versus 0 [0; 1] and 2 [1,5; 2] versus 2 [2; 3] points), which can reflect cardiomyocyte destruction/depletion at later stages of the disease. There was also a close correlation between the expression level of TLR2 and that of TLR9 (r=0.824; p<0.001) and with Ki-67 levels (r=–0.531 and r=–0.702; p<0.01). There was also a correlation of the expression of the studied markers with viral persistence (desmin), the degree of myocardial dysfunction and cardiosclerosis (c-kit), which calls for further investigations. Conclusion. Determination of the myocardial expression level of TLR2 and TLR9 may serve as an immunohistochemical marker for myocarditis and preservation of its activity, which is especially valuable in patients with borderline forms. The marked expression of these markers for innate immunity may reflect both one of the mechanisms of genetic predisposition to myocarditis and its severe course and their secondary activation in the pathogenesis of the disease and is a potential target of therapy.

Keywords:

myocarditis

endomyocardial biopsy

toll-like receptors 2 and 9

immunohistochemical examination

immunosuppressive therapy

Authors:

Kogan E.A.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Blagova O.V.

GBOU VPO Pervyĭ MGMU im. I.M. Sechenova

Faĭzullina N.M.

FGBU "NTsAGiP im. akad. V.I Kulakova" Minzdrava Rossii, Moskva

Nedostup A.V.

GBOU VPO Pervyĭ MGMU im. I.M. Sechenova

Sulimov V.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

List of references:

Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648,2648a-48d. https://doi.org/10.1093/eurheartj/eht210
Maisch B, Portig I, Ristic A, Hufnagel G, Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz. 2000;25(3):200-209. https://doi.org/10.1007/s000590050007
Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rьdiger M, Boehm O, Fink K, Dreiner U, Grohй C, Hoeft A, Baumgarten G, Koch A, Zacharowski K, Meyer R. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovasc Res. 2008;78(1):26-35. https://doi.org/10.1093/cvr/cvn011
Hasham MG, Baxan N, Stuckey DJ, Branca J, Perkins B, Dent O4, Duffy T, Hameed TS, Stella SE, Bellahcene M, Schneider MD, Harding SE, Rosenthal N, Sattler S. Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease. Dis Model Mech. 2017;10(3):259-270. https://doi.org/10.1242/dmm.027409
Feng Y, Chao W. Toll-like receptors and myocardial inflammation. Int J Inflam. 2011;2011:170352. https://doi.org/10.4061/2011/170352
Mann DL. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res. 2011;108(9):1133-1145. https://doi.org/10.1161/CIRCRESAHA.110.226936
Souza BS, Azevedo CM, d Lima RS, Kaneto CM, Vasconcelos JF, Guimarгes ET, dos Santos RR, Soares MB. Bone marrow cells migrate to the heart and skeletal muscle and participate in tissue repair after Trypanosoma cruzi infection in mice. Int J Exp Pathol. 2014;95(5):321-329. https://doi.org/10.1111/iep.12089
Arbustini E, Diegoli M, Grasso M, Fasani R, D’Armini A, Martinelli L, Goggi C, Campana C, Gavazzi A, Viganт M. Expression of proliferating cell markers in normal and diseased human hearts. Am J Cardiol. 1993;72(7):608-614. https://doi.org/10.1016/0002-9149(93)90360-o
Frustaci A, Chimenti C, Pieroni M, Salvatori L, Morgante E, Sale P, Ferretti E, Petrangeli E, Gulino A, Russo MA. Cell death, proliferation and repair in human myocarditis responding to immunosuppressive therapy. Mod Pathol. 2006;19(6):755-765. https://doi.org/10.1038/modpathol.3800594
Argьello RJ, Vigliano C, Cabeza-Meckert P, Viotti R, Garelli F, Favaloro LE, Favaloro RR, Laguens R, Laucella SA. Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis. PLoS Negl Trop Dis. 2014;8(8):e2989. https://doi.org/10.1371/journal.pntd.0002989
Sin J, Puccini JM, Huang C, Konstandin MH, Gilbert PE, Sussman MA, Gottlieb RA, Feuer R. The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development. PLoS Pathog. 2014;10(7):e1004249. https://doi.org/10.1371/journal.ppat.1004249
Hammer E, Phong TQ, Steil L, Klingel K, Salazar MG, Bernhardt J, Kandolf R, Kroemer HK, Felix SB, Vцlker U. Viral myocarditis induced by Coxsackievirus B3 in A.BY/SnJ mice: analysis of changes in the myocardial proteome. Proteomics. 2010;10(9):1802-1818. https://doi.org/10.1002/pmic.200900734
Zhu Y, Mao Z, Lou D, Zhang H. The expression of connexin 43 and desmin in viral myocarditis. Zhonghua Bing Li Xue Za Zhi. 2000;29(4):288-290.
Zhao P, Sharma AC, Ren J. Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy. Front Biosci (Landmark Ed). 2009;14:1708-1715. https://doi.org/10.2741/3334
Osipova YuV, Blagova OV, Nedostup AV, Kogan EA, Sulimov VA, Frolova YuV, Dzemeshkevich SL, Donnikov AE, Kadochnikova VV, Kupriyanova AG, Zaidenov VA. Significance of different non-invasive markers in diagnosis of latent myocarditis in comparison with biopsy data. Kardiologiya i serdechno-sosudistaya khirurgiya. 2015;8(1):40-56. (In Russ.) https://doi.org/10.17116/kardio20158140-56
Lassner D, Kьhl U, Siegismund CS, Rohde M, Elezkurtaj S, Escher F, Tschцpe C, Gross UM, Poller W, Schultheiss HP. Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling. Eur Heart J. 2014;35(32):2186-2195. https://doi.org/10.1093/eurheartj/ehu101
Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem. 2010;285(30):23208-23223. https://doi.org/10.1074/jbc.M109.047464
Belkaya S, Kontorovich AR, Byun M, Mulero-Navarro S, Bajolle F, Cobat A, Josowitz R, Itan Y, Quint R, Lorenzo L, Boucherit S, Stoven C, Di Filippo S, Abel L, Zhang SY, Bonnet D, Gelb BD, Casanova JL. Autosomal recessive cardiomyopathy presenting as acute myocarditis. J Am Coll Cardiol. 2017;69(13):1653-1665. https://doi.org/10.1016/j.jacc.2017.01.043
Ruppert V, Meyer T, Pankuweit S, Mцller E, Funck RC, Grimm W, Maisch B; German Heart Failure Network. Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2008;136(2):360-9.e1. https://doi.org/10.1016/j.jtcvs.2008.03.016
Satoh M, Nakamura M, Akatsu T, Iwasaka J, Shimoda Y, Segawa I, Hiramori K. Expression of Toll-like receptor 4 is associated with enteroviral replication in human myocarditis. Clin Sci (Lond). 2003;104(6):577-584. https://doi.org/10.1016/s0195-668x(03)96168-9
Chimenti C, Scopelliti F, Verardo R, Grande C, Fedele F, Frustaci A. Toll-like receptor 4 is a marker of immune-mediated damage in patients with inflammatory cardiomyopathy. Eur Heart J. 2013;34(Suppl.1):abstr.689. [Abstracts of the ESC (European Society of Cardiology) Congress 2013. Amsterdam, Netherlands. August 31-September 4, 2013.].
Boza P, Ayala P, Vivar R, Humeres C, Cбceres FT, Muсoz C, Garcнa L, Hermoso MA, Dнaz-Araya G. Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1в synthesis, secretion, and degradation. Mol Immunol. 2016;74:96-105. https://doi.org/10.1016/j.molimm.2016.05.001
Yang J, Guo X, Yang J, Ding JW, Li S, Yang R, Fan ZX, Yang CJ. RP105 Protects against apoptosis in ischemia/reperfusion-induced myocardial damage in rats by suppressing TLR4-mediated signaling pathways. Cell Physiol Biochem. 2015;36(6):2137-2148. https://doi.org/10.1159/000430180
Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W, Deng C, Fan C, Di S, Sun Y, Yi W. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis. 2016;7:e2234. https://doi.org/10.1038/cddis.2016.140
Chimenti C, Verardo R, Scopelliti F, Grande C, Petrosillo N, Piselli P, De Paulis R, Frustaci A. Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathy. Eur J Heart Fail. 2017;19(7):915-925. https://doi.org/10.1002/ejhf.796
Blagova OV, Nedostup AV, Kogan EA, Sedov VP, Gagarina NV, Donnikov AE, Kupryanova AG, Zaidenov VA. Immunosupressive and antiviral therapy of virus-positive and virus-negative inflammatory cardiomyopathy: short-term results and outcomes. Eur Heart J. 2013;34(Suppl.1):abstr.613. [Abstracts of the ESC (European Society of Cardiology) Congress 2013. Amsterdam, Netherlands. August 31-September 4, 2013.].
McDaniel DO, Zhou X, Moore CK, Aru G. Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1. Transplant Proc. 2010;42(10):4235-4237. https://doi.org/10.1016/j.transproceed.2010.09.091

Close metadata